Category Archives: patient compliance
By Clark Herman | Published: April 5, 2013
They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales. A GSW Worldwide report titled The non-physician prescriber will see you now points [...]
By Guest Blogger | Published: April 1, 2013
Patient adherence to medicine is the eternal puzzle for big Pharma: what combinations of financial incentives, personalized interventions, and just good information work best to push down that stubborn 50 per cent abandonment threshold after six months of treatment? Certainly there are plenty of new programs on the market, so Pharm Exec believes it’s time [...]
By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from DNA, which are instructions much like a blueprint. Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
By Ben Comer | Published: November 7, 2012
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence.
By Ben Comer | Published: August 1, 2012
FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.